AI-generated summary
The authors treated 20 patients with biopsy-confirmed facial squamous cell carcinoma in situ using aminolevulinic acid gel and red light in two sessions. They report complete histologic and clinical clearance in all patients, with no treatment-related adverse events and mostly mild, temporary skin reactions. The study was small and uncontrolled, so the findings are preliminary.
- Participants
- 20
- Who or what was studied
- Twenty adults with biopsy-confirmed facial cutaneous squamous cell carcinoma in situ (lesions 0.4 to 1.3 cm)
- Limits stated in the abstract
- The abstract describes a small single-arm study of 20 patients without a control group, so results cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Red light therapy, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.